Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedMinor version update noted: v3.4.2 has been added and v3.4.1 removed. This appears to be a maintenance change rather than a change to study data or user actions.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to study details or page layout are observed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedPublication source description changed from 'These publications come from PubMed... automatically created by ClinicalTrials.gov Identifier (NCT Number)' to 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study', and the revision tag updated from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedRemoved the banner notice about lapse in government funding and potential data delays. The notice previously directed users to cc.nih.gov and opm.gov for operating status updates.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.